Connecting to Research

Why is Research Important?

In the absence of a medical breakthrough to prevent, slow, or cure Alzheimer’s, 13.8 million Americans age 65 and older will have the disease by 2050.¹ Thus, research into preventive strategies, earlier diagnosis, and treatment is critically important. Currently, there are hundreds of actively enrolling clinical trial sites across the country for people with mild cognitive impairment, Alzheimer’s disease or other dementias and their care partners. Most are looking for people just like you to help them in the race for the cure.

The Power of Diversity

Although older Black and Hispanic Americans are more likely to have Alzheimer’s or other dementias than White Americans, which is likely due in part to health and healthcare disparities, fewer participate in research or clinical trials.¹ Without participation by Black, Hispanic, Asian, Native Americans, and other people of color, a complete understanding of how racial and ethnic differences may impact potential new treatments is impossible. Social justice demands that new treatments are safe, available and effective for communities of color. It is clear that in the race for a cure, people of color play an essential role.

Without you, there can be no better treatments or, one day, a cure for Alzheimer’s disease or related dementias.

Click here to read about what’s it like to be in a clinical trial.

Increasing participation in research is a key aim of MAP. To find a clinical trial near you, visit:
National Institutes of Health Alzheimers.gov
Alzheimer’s Association Trial Match
Antidote Clinical Trial Matching Site

1) 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021 Mar 23. doi: 10.1002/alz.12328. Epub ahead of print.